AI Verdict
NYT has stronger fundamentals based on our AI analysis.
OACCW vs NYT Fundamental Comparison
| Metric | OACCW | NYT |
|---|---|---|
| Revenue | N/A | $2.8B |
| Net Income | $7.3M | $344.0M |
| Net Margin | N/A | 12.2% |
| ROE | N/A | 16.9% |
| ROA | 3.6% | 11.5% |
| Current Ratio | 1.19x | 1.54x |
| Debt/Equity | N/A | 0.12x |
| EPS | N/A | $2.09 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
OACCW vs NYT: Frequently Asked Questions
Is OACCW or NYT a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NYT has stronger fundamentals. OACCW is rated SELL (72% confidence) while NYT is rated BUY (72% confidence). This is not investment advice.
How does OACCW compare to NYT fundamentally?
Oaktree Acquisition Corp. III Life Sciences has ROE of N/A vs NEW YORK TIMES CO's 16.9%. Net margins are N/A vs 12.2% respectively.
Which stock pays higher dividends, OACCW or NYT?
OACCW has a dividend yield of N/A or no dividend while NYT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in OACCW or NYT for long term?
For long-term investing, consider that OACCW has SELL rating with 72% confidence, while NYT has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about OACCW vs NYT?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For OACCW vs NYT, the AI consensus favors NYT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.